Hydroxyurea therapy in chronic myelogenous leukemia.
D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D002066:Busulfan / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004351:Drug Resistance; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D007958:Leukocyte Count; D013163:Splenomegaly / Q000517:prevention & control; D013922:Thrombocytosis / Q000517:prevention & control
D002066:Busulfan; D006918:Hydroxyurea